Lymph nodes are key sites for the development of tissue-specific adaptive immunity, and their spaced distribution among tissues facilitates simultaneous immune decision-making in different organs. Some lymph nodes may serve multiple organs at the same time, and these shared lymph nodes may result in the shared organs being more susceptible to immune crosstalk, and the mechanism of how the lymph nodes integrate the complex information and respond accordingly to such a scenario is still not clear. The mechanism of how lymph nodes integrate complex information and respond accordingly in this situation remains unclear.

The miR-295 cluster also promoted the expression of mesenchymal-epithelial transition (MET) marker genes. Conclusion:The miR-290-295 cluster has a promotional effect on mouse somatic cell reprogramming, which contributes to a deeper understanding of the RNA-regulated mechanism of stem cell pluripotency and reprogramming, and provides a new perspective for the development of novel induction systems.

BW-03 is a new siRNA (Small Interfering Nucleic Acid) drug for the treatment of Chronic Hepatitis B (CHB) developed in-house by Hublot Pharmaceuticals utilizing the platform technology RADS.

The nominated PCC targets biological targets that play a key role in DNA damage repair mechanisms, and is one of the four targets of interest proposed by Fosun Pharma when the collaboration was initiated.